Skip to main content

Table 3 Stratification analysis of lncRNA MALAT1 polymorphisms and clinical features of CAD

From: Association of polymorphisms in MALAT1 with risk of coronary atherosclerotic heart disease in a Chinese population

Genotypes

TCH (mmol/L)

TG (mmol/L)

HDL-C (mmol/L)

LDL-C (mmol/L)

Mean ± SD

P value

Mean ± SD

P value

Mean ± SD

P value

Mean ± SD

P value

rs11227209

 CC

4.95 ± 0.74

 

1.95 ± 1.07

 

1.33 ± 0.36

 

2.69 ± 0.67

 

 CG/GG

4.72 ± 0.86

0.02

1.95 ± 1.02

0.94

1.34 ± 0.40

0.86

2.82 ± 0.80

0.13

rs619586

 AA

4.94 ± 0.77

 

1.98 ± 1.07

 

1.32 ± 0.36

 

2.69 ± 0.68

 

 AG/GG

4.76 ± 0.79

0.04

1.85 ± 1.01

0.27

1.37 ± 0.41

0.25

2.81 ± 0.77

0.11

rs664589

 CC

4.93 ± 0.74

 

1.97 ± 1.08

 

1.32 ± 0.36

 

2.71 ± 0.70

 

 CG/GG

4.84 ± 0.85

0.28

1.92 ± 1.00

0.67

1.36 ± 0.39

0.21

2.72 ± 0.71

0.87

rs3200401

 CC

4.95 ± 0.75

 

1.98 ± 1.05

 

1.33 ± 0.36

 

2.70 ± 0.69

 

 CT/TT

4.77 ± 0.81

0.02

1.87 ± 1.07

0.29

1.35 ± 0.39

0.61

2.74 ± 0.72

0.58

  1. CAD coronary atherosclerotic heart disease, TCH total cholesterol, SD standard deviation, TG triglyceride, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol